Tb-161 Purification by high performance ion chromatography (HPIC) from irradiated Gd-160: Poster Category: Radiochemistry ‐ Radiometals

Research output: Contribution to report/book/conference proceedingsIn-proceedings paperpeer-review

Institutes & Expert groups

Documents & links

DOI

Abstract

161Tb has many attractive properties (half‐life of 6.9 d, β−decay energy of 593 keV, conversion and Auger electron emission) for targeted radionuclide therapy with peptides and antibodies.1 161Tb can be produced via neutron irradiation of 160Gd in a nuclear reactor, such as BR2(flux of circa 1014 neutrons cm−2 s−1) at SCK•CEN. The aim of this project was to develop a fast and easy method
to purify small amounts (circa 250 MBq) of n.c.a. 161Tb with high specific activity, for radiolabeling studies and in‐house chelator design

Details

Original languageEnglish
Title of host publicationSupplement: The 23rd International Symposium on Radiopharmaceutical Sciences (ISRS 2019) Beijing, China, 26–31 May 2019
PagesS303-S303
Number of pages1
Volume62
DOIs
Publication statusPublished - 24 May 2019
EventISRS 2019 - SRS Office, Beijing, China
Duration: 26 May 201931 May 2019
https://www.srsweb.org/isrs2019

Publication series

NameJournal of Labelled Compounds and Radiopharmaceuticals
PublisherWiley - John Wiley & Sons, Ltd
ISSN (Print)0362-4803

Conference

ConferenceISRS 2019
Country/TerritoryChina
CityBeijing
Period2019-05-262019-05-31
Internet address

Keywords

  • BR2, 161Tb

ID: 7323573